Intercept to Present at the Jefferies Virtual Healthcare Conference
Intercept Pharmaceuticals (Nasdaq: ICPT) announced that CEO Jerry Durso will present at the Jefferies Virtual Healthcare Conference on June 3, 2021, at 11:30 a.m. ET. The event will be accessible via a live webcast on the company’s investor page.
Intercept specializes in developing treatments for progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Founded in 2002, the company operates in the U.S., Europe, and Canada.
- None.
- None.
NEW YORK, May 27, 2021 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that Jerry Durso, President and Chief Executive Officer of Intercept, will present at the Jefferies Virtual Healthcare Conference on Thursday, June 3, 2021 at 11:30 a.m. ET.
A live webcast of the event will be available on the investor page of Intercept’s website at http://ir.interceptpharma.com. An audio archive of the webcast will also be available on Intercept’s website for approximately two weeks.
About Intercept
Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Founded in 2002 in New York, Intercept has operations in the United States, Europe and Canada. For more information, please visit www.interceptpharma.com or connect with the company on Twitter and LinkedIn.
CONTACT
For more information about Intercept, please contact:
Investor inquiries: investors@interceptpharma.com
Media inquiries: media@interceptpharma.com
Source: Intercept Pharmaceuticals, Inc.
FAQ
When is Jerry Durso's presentation at the Jefferies Virtual Healthcare Conference?
Where can I watch the live webcast of Intercept Pharmaceuticals' event?
What is the focus of Intercept Pharmaceuticals?
What is the stock symbol for Intercept Pharmaceuticals?